Baidu
map

2021年7月13日简报:中国国药和科兴新冠疫苗进入COVAX疫苗库,加拿大混合接种疫苗,疫情控制良好

2021-07-13 MedSci整理 MedSci整理

截至北京时间2021年7月13日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过18802万例,新增370,316例,达到188,026,64

截至北京时间2021年7月13日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过18802万例,新增370,316例,达到188,026,648例。累计死亡病例405.5万例,达到4,055,253例。新增死亡为6,101例。康复为171,974,116例,重症和危重症病人达到78,510例;全球新冠确诊病例超过100万例的国家达29个,98个国家病例超10万例。昨日报道:2021年7月12日简报:新增新冠肺炎36.5万例,全球多国疫情失控,疫苗仍然是最可靠的控制疫情手段之一

全球首例!同时感染两种新冠变异毒株,确诊5天后去世

在当地时间11日举行的欧洲临床微生物和传染病(ECCMID)大会上,比利时研究人员公布了一项研究称,一名90岁比利时女性同时感染了两种新冠病毒变体,这是迄今为止全球首例有正式记录的此类病例。科学家警告,需要进行更多的研究,以防止同时感染多种新冠病毒变异毒株。

据悉,这位老人已于今年3月因新冠肺炎不幸离世。今年3月,她在多次摔倒后被送入比利时阿尔斯特市OLV的医院,入院当天的新冠检测结果呈阳性,未接种疫苗。最初,这位老人的血氧水平很稳定,但是健康状况急剧恶化,并于五天后死亡。随后,样本检测结果显示,她的体内同时携带了英国“阿尔法”和南非“贝塔”新冠变异毒株。

事实上,早在今年1月就有巴西科学家报告称,有两人同时感染了两种不同的新冠病毒毒株,但该研究尚未发表在科学期刊上。近期,葡萄牙的研究人员也表示,医护人员在治疗一名17岁患者的过程中发现,这名患者似乎在感染第一种变异毒株后的恢复期内,又感染了另一种毒株。

中国已向100多个国家和国际组织提供了5亿剂新冠疫苗和原液

截至目前,中国已向全球100多个国家和国际组织提供了5亿剂新冠疫苗和原液,相当于当前全球新冠疫苗总产量的六分之一。中国企业为世界卫生 组织主导的“新冠肺炎疫苗实施计划”生产的疫苗也已下线,将尽快向世卫组织提供。

中国国药和科兴新冠疫苗进入“新冠肺炎疫苗实施计划”疫苗库

全球疫苗免疫联盟(GAVI)12日发布新闻公报,宣布已同中国国药集团和科兴公司分别签署了预购协议,这意味着国药疫苗和科兴疫苗进入“新冠肺炎疫苗实施计划”(COVAX)疫苗库,并可从7月开始向COVAX供应疫苗以用于发展中国家的新冠疫情防控。

COVAX由世界卫生组织、全球疫苗免疫联盟等主导。新闻公报介绍,考虑到这两种疫苗已经进入世卫组织紧急使用清单,可以立即向COVAX各参与方供货。根据协议,两家中国公司今年10月底前可向COVAX供货1.1亿剂新冠疫苗,后续长期供货。

从今年7月开始到明年上半年,两家企业承诺将会给“新冠肺炎疫苗实施计划”供应5.5亿剂新冠疫苗。

美国日增确诊病例超2万例 多地成为新冠疫情热点地区

根据Worldometer实时统计数据,截至北京时间7月13日6时30分左右,美国累计确诊新冠肺炎病例34752630例,累计死亡病例622952例。与前一日6时30分数据相比,美国新增确诊病例21037例,新增死亡病例107例。

据美国媒体于当地时间7月12日报道,美国多地成为新冠疫情热点地区,感染病例数不断攀升。专家警告称,疫情死亡人数或将延后上升。专家表示,从宏观数据层面,在确诊病例数激增后三到四周内将可以观测到死亡率的上升。专家指出,尤其是在密苏里州部分地区,目前有91%的重症监护室患者使用呼吸机,然而在2020年疫情高峰期该地仅有40%到50%的呼吸机使用率,密苏里州的状况令人担忧。

印度日增确诊病例超3.7万例 中央武装警察部队超8.4万人确诊新冠

据印度卫生部12日公布的最新数据,印度新冠肺炎确诊病例升至30874376例。在过去24小时内,印度新增确诊病例37154例;新增死亡病例724例,累计死亡病例408764例。

据印度媒体报道,根据印度内政部最新数据,该部门下属的印度中央武装警察部队(CAPF)累计已报告超过8.4万例新冠肺炎确诊病例,331人感染后死亡。

美国财长耶伦非常担心变种新冠病毒可能威胁到全球经济复苏

美国财长耶伦表示,非常担心变种新冠病毒可能威胁到全球经济复苏。耶伦在意大利出席20国集团会议后指,Delta和其他变种病毒可能威胁经济复苏,指全球经济是相互联繫,世界上任何地方发生的事情,都会影响到所有其他国家。

耶伦续指,公平分配疫苗是抗疫的最佳途径,共同努力加快疫苗接种进程很重要,目标是明年为全球70%人口接种疫苗。

国台办:9.9万名台胞已在大陆接种新冠疫苗

截至6月30日,在大陆接种疫苗的台胞已达9.9万人,接种剂次约17.4万剂。

马晓光说,搭乘民航客运航班来大陆的台胞,只要符合接种条件,可在严格执行入境防疫规定(包括登机前和登机后),自愿和知情同意前提下,按有关政策在大陆接种疫苗。

加拿大混合接种疫苗,疫情控制良好

根据加拿大联邦公共卫生局最新发布的数据,截至今天加拿大居民已接种了超过 4100万剂新冠疫苗,超过2600万人已经至少接种了一剂疫苗,占符合接种条件人口的77.9%。而在12岁及以上的人群中,已有1500万人完全接种了两剂疫苗,接种比例达到44.8%。

加拿大联邦公共卫生局首席卫生官谭咏诗表示,如果能继续保持目前的接种速度,加拿大有望完成80%的接种范围,达到群体免疫。

全球疫苗接种概况

Country
Cumulative COVID-19 vaccinations doses
World 3.44 billion
Asia 2.15 billion
Upper middle income 1.81 billion
China 1.38 billion
High income 1.06 billion
Lower middle income 565.61 million
Europe 558.42 million
North America 455.09 million
European Union 403.18 million
India 377.35 million
United States 334.15 million
South America 209.58 million
Brazil 114.46 million
Germany 81.94 million
United Kingdom Jul 10, 2021 80.65 million
England Jul 10, 2021 67.62 million
Japan 60.26 million
France Jul 8, 2021 59.12 million
Turkey 58.16 million
Italy 57.62 million
Africa 55.39 million
Indonesia 51.28 million
Mexico Jul 10, 2021 50.70 million
Russia 47.57 million
Spain Jul 8, 2021 46.61 million
Canada 42.51 million
Poland 31.54 million
Argentina 24.62 million
Chile Jul 9, 2021 24.05 million
Colombia 21.12 million
South Korea 20.33 million
Pakistan 19.88 million
Saudi Arabia 19.83 million
Morocco 19.58 million
Netherlands 17.19 million
United Arab Emirates 15.93 million
Philippines 13.12 million
Thailand 12.57 million
Belgium Jul 8, 2021 11.84 million
Malaysia 11.37 million
Oceania 11.21 million
Israel 10.92 million
Hungary Jun 27, 2021 10.16 million
Bangladesh Jul 8, 2021 10.11 million

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1632405, encodeId=8be4163240598, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Fri Dec 17 02:51:23 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312674, encodeId=f8c813126e40f, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Wed Jul 14 22:51:23 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999186, encodeId=4c3c999186d3, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11285395406, createdName=ms1000001799280342, createdTime=Tue Jul 13 20:02:15 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999067, encodeId=432799906ea5, content=已读,学习,学习。真是受益匪浅呀!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Tue Jul 13 11:52:49 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999059, encodeId=afb399905970, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc5b5547663, createdName=紫金砂, createdTime=Tue Jul 13 11:10:40 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029731, encodeId=c6e71029e31ba, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jul 13 10:51:23 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999007, encodeId=e17799900ee1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edee5452494, createdName=ms5000002032253415, createdTime=Tue Jul 13 08:41:01 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998997, encodeId=852e99899e86, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210326/ff8ca31266094a0b96cc76af821329a9/d16b54784def45618f5a6696eae074c6.jpg, createdBy=e00e5468294, createdName=GY058774, createdTime=Tue Jul 13 08:16:07 CST 2021, time=2021-07-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1632405, encodeId=8be4163240598, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Fri Dec 17 02:51:23 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312674, encodeId=f8c813126e40f, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Wed Jul 14 22:51:23 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999186, encodeId=4c3c999186d3, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11285395406, createdName=ms1000001799280342, createdTime=Tue Jul 13 20:02:15 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999067, encodeId=432799906ea5, content=已读,学习,学习。真是受益匪浅呀!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Tue Jul 13 11:52:49 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999059, encodeId=afb399905970, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc5b5547663, createdName=紫金砂, createdTime=Tue Jul 13 11:10:40 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029731, encodeId=c6e71029e31ba, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jul 13 10:51:23 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999007, encodeId=e17799900ee1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edee5452494, createdName=ms5000002032253415, createdTime=Tue Jul 13 08:41:01 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998997, encodeId=852e99899e86, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210326/ff8ca31266094a0b96cc76af821329a9/d16b54784def45618f5a6696eae074c6.jpg, createdBy=e00e5468294, createdName=GY058774, createdTime=Tue Jul 13 08:16:07 CST 2021, time=2021-07-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1632405, encodeId=8be4163240598, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Fri Dec 17 02:51:23 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312674, encodeId=f8c813126e40f, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Wed Jul 14 22:51:23 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999186, encodeId=4c3c999186d3, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11285395406, createdName=ms1000001799280342, createdTime=Tue Jul 13 20:02:15 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999067, encodeId=432799906ea5, content=已读,学习,学习。真是受益匪浅呀!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Tue Jul 13 11:52:49 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999059, encodeId=afb399905970, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc5b5547663, createdName=紫金砂, createdTime=Tue Jul 13 11:10:40 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029731, encodeId=c6e71029e31ba, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jul 13 10:51:23 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999007, encodeId=e17799900ee1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edee5452494, createdName=ms5000002032253415, createdTime=Tue Jul 13 08:41:01 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998997, encodeId=852e99899e86, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210326/ff8ca31266094a0b96cc76af821329a9/d16b54784def45618f5a6696eae074c6.jpg, createdBy=e00e5468294, createdName=GY058774, createdTime=Tue Jul 13 08:16:07 CST 2021, time=2021-07-13, status=1, ipAttribution=)]
    2021-07-13 ms1000001799280342

    很好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1632405, encodeId=8be4163240598, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Fri Dec 17 02:51:23 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312674, encodeId=f8c813126e40f, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Wed Jul 14 22:51:23 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999186, encodeId=4c3c999186d3, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11285395406, createdName=ms1000001799280342, createdTime=Tue Jul 13 20:02:15 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999067, encodeId=432799906ea5, content=已读,学习,学习。真是受益匪浅呀!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Tue Jul 13 11:52:49 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999059, encodeId=afb399905970, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc5b5547663, createdName=紫金砂, createdTime=Tue Jul 13 11:10:40 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029731, encodeId=c6e71029e31ba, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jul 13 10:51:23 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999007, encodeId=e17799900ee1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edee5452494, createdName=ms5000002032253415, createdTime=Tue Jul 13 08:41:01 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998997, encodeId=852e99899e86, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210326/ff8ca31266094a0b96cc76af821329a9/d16b54784def45618f5a6696eae074c6.jpg, createdBy=e00e5468294, createdName=GY058774, createdTime=Tue Jul 13 08:16:07 CST 2021, time=2021-07-13, status=1, ipAttribution=)]
    2021-07-13 ms5000000518166734

    已读,学习,学习。真是受益匪浅呀!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1632405, encodeId=8be4163240598, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Fri Dec 17 02:51:23 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312674, encodeId=f8c813126e40f, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Wed Jul 14 22:51:23 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999186, encodeId=4c3c999186d3, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11285395406, createdName=ms1000001799280342, createdTime=Tue Jul 13 20:02:15 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999067, encodeId=432799906ea5, content=已读,学习,学习。真是受益匪浅呀!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Tue Jul 13 11:52:49 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999059, encodeId=afb399905970, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc5b5547663, createdName=紫金砂, createdTime=Tue Jul 13 11:10:40 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029731, encodeId=c6e71029e31ba, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jul 13 10:51:23 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999007, encodeId=e17799900ee1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edee5452494, createdName=ms5000002032253415, createdTime=Tue Jul 13 08:41:01 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998997, encodeId=852e99899e86, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210326/ff8ca31266094a0b96cc76af821329a9/d16b54784def45618f5a6696eae074c6.jpg, createdBy=e00e5468294, createdName=GY058774, createdTime=Tue Jul 13 08:16:07 CST 2021, time=2021-07-13, status=1, ipAttribution=)]
    2021-07-13 紫金砂

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1632405, encodeId=8be4163240598, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Fri Dec 17 02:51:23 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312674, encodeId=f8c813126e40f, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Wed Jul 14 22:51:23 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999186, encodeId=4c3c999186d3, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11285395406, createdName=ms1000001799280342, createdTime=Tue Jul 13 20:02:15 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999067, encodeId=432799906ea5, content=已读,学习,学习。真是受益匪浅呀!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Tue Jul 13 11:52:49 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999059, encodeId=afb399905970, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc5b5547663, createdName=紫金砂, createdTime=Tue Jul 13 11:10:40 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029731, encodeId=c6e71029e31ba, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jul 13 10:51:23 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999007, encodeId=e17799900ee1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edee5452494, createdName=ms5000002032253415, createdTime=Tue Jul 13 08:41:01 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998997, encodeId=852e99899e86, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210326/ff8ca31266094a0b96cc76af821329a9/d16b54784def45618f5a6696eae074c6.jpg, createdBy=e00e5468294, createdName=GY058774, createdTime=Tue Jul 13 08:16:07 CST 2021, time=2021-07-13, status=1, ipAttribution=)]
    2021-07-13 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1632405, encodeId=8be4163240598, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Fri Dec 17 02:51:23 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312674, encodeId=f8c813126e40f, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Wed Jul 14 22:51:23 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999186, encodeId=4c3c999186d3, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11285395406, createdName=ms1000001799280342, createdTime=Tue Jul 13 20:02:15 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999067, encodeId=432799906ea5, content=已读,学习,学习。真是受益匪浅呀!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Tue Jul 13 11:52:49 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999059, encodeId=afb399905970, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc5b5547663, createdName=紫金砂, createdTime=Tue Jul 13 11:10:40 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029731, encodeId=c6e71029e31ba, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jul 13 10:51:23 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999007, encodeId=e17799900ee1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edee5452494, createdName=ms5000002032253415, createdTime=Tue Jul 13 08:41:01 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998997, encodeId=852e99899e86, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210326/ff8ca31266094a0b96cc76af821329a9/d16b54784def45618f5a6696eae074c6.jpg, createdBy=e00e5468294, createdName=GY058774, createdTime=Tue Jul 13 08:16:07 CST 2021, time=2021-07-13, status=1, ipAttribution=)]
    2021-07-13 ms5000002032253415

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1632405, encodeId=8be4163240598, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Fri Dec 17 02:51:23 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312674, encodeId=f8c813126e40f, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Wed Jul 14 22:51:23 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999186, encodeId=4c3c999186d3, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11285395406, createdName=ms1000001799280342, createdTime=Tue Jul 13 20:02:15 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999067, encodeId=432799906ea5, content=已读,学习,学习。真是受益匪浅呀!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Tue Jul 13 11:52:49 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999059, encodeId=afb399905970, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc5b5547663, createdName=紫金砂, createdTime=Tue Jul 13 11:10:40 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029731, encodeId=c6e71029e31ba, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jul 13 10:51:23 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999007, encodeId=e17799900ee1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edee5452494, createdName=ms5000002032253415, createdTime=Tue Jul 13 08:41:01 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998997, encodeId=852e99899e86, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210326/ff8ca31266094a0b96cc76af821329a9/d16b54784def45618f5a6696eae074c6.jpg, createdBy=e00e5468294, createdName=GY058774, createdTime=Tue Jul 13 08:16:07 CST 2021, time=2021-07-13, status=1, ipAttribution=)]
    2021-07-13 GY058774

    有意义

    0

相关资讯

全国新冠疫苗接种剂次超13亿,各个省市哪家强大?

据国家卫健委通报,截至2021年7月10日24时,31个省份和新疆兵团累计确诊病例92039例,比昨日新增确诊病例24例,其中境外输入病例12例(云南4例,上海3例,四川2例,广东1例,广西1例,陕西

Nat Commun:武汉地区的新冠康复者血清抗体能持续多久?

新冠感染康复后人体内新冠抗体可以持续多久,一直是人们关注的热点。

2021年7月12日简报:新增新冠肺炎36.5万例,全球多国疫情失控,疫苗仍然是最可靠的控制疫情手段之一

截至北京时间2021年7月12日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过18761万例,新增365,453例,达到187,612,07

手机屏幕采样可检测病毒,阿斯利康疫苗引起血栓原因被发现:新冠研究一周进展

近日,发表于eLife的一项工作中,研究团队开发的手机屏幕检测(PoST)方法,可以利用从手机屏幕上采集的样本来检测新冠病毒。通过常规鼻拭子检测呈阳性的人员从手机屏幕取样也呈阳性,且在81%至100%

Lancet:中国科兴新冠疫苗可100%预防住院

近期土耳其哈切特佩大学医学院等研究机构对中国科兴新冠肺炎疫苗展开了三期随机对照临床试验,涉及超过1万名18岁至59岁的志愿者试验过程中,一部分志愿者接种安慰剂,另一部分人间隔14天接种了两剂&ldqu

2021年7月11日全球新冠肺炎疫情及疫苗接种简报:全球疫情分布不均,新一波疫情正在到来,疫情正深刻改变世界

截至北京时间2021年7月10日8时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过18681万例,新增485,093例,达到186,812,15

Baidu
map
Baidu
map
Baidu
map